Results 131 to 140 of about 20,028 (211)

PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosis. [PDF]

Atheroscler Plus
Amorosi A, Varret M.
europepmc   +1 more source

Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis. [PDF]

Medicine (Baltimore)
Du W, Li D, Li N, Zhang W, Wang J, Wang T, Zeng Y.   +6 more
europepmc   +1 more source

Correction: Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives

Frontiers in Pharmacology
Seyed Saeed Tamehri Zadeh, Peter P. Toth, Peter P. Toth, Maciej Banach, Maciej Banach   +4 more
doaj   +1 more source

High-efficacy serum biomarkers PCSK9 and LCAT predict cognitive impairment in Parkinson's disease. [PDF]

Front Psychol
Su M, Yang T, Fan X, Qiang X, Liao Z, Gu H, Gao L, Chen R, Tang C, Mu C.   +9 more
europepmc   +1 more source

RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside. [PDF]

Research (Wash D C)
Ali I, Qiu J, Cheang WS, Wang G, Xu S.
europepmc   +1 more source

PCSK9 Inhibitors and Bipolar Disorder: A Drug Target Mendelian Randomization Study. [PDF]

Clin Neuropharmacol
Li J, Yao PS.
europepmc   +1 more source

Small-molecule PCSK9 inhibition enhances BBB amyloid-β clearance and suppresses microglial inflammation in Alzheimer's disease models. [PDF]

Sci Rep
Miao J, Wang J, Zhou W, Guo J.
europepmc   +1 more source

Pharmacogenomics of Atherosclerotic Plaque: Pathophysiological Background and Therapeutic Perspectives. [PDF]

Curr Atheroscler Rep
Mauriello A, De Falco A, Correra A, D'Andrea A, Giallauria F, Giordano A, Russo V.   +6 more
europepmc   +1 more source

Role of Hyperlipidemia-Related <i>PCSK9</i>, <i>APOE</i>, and <i>LRP8</i> Variants in Restenosis after Stent Implantation in Male Patients: A Case-Control Study. [PDF]

Mol Syndromol
Ozkara G, Aslan EI, Ser OS, Kilicarslan O, Kucukhuseyin O, Bostan C, Yildiz A, Ozturk O, Yilmaz-Aydogan H.   +8 more
europepmc   +1 more source